Develops ingestible capsule-based medical device platforms and plans to generate revenue from sales via distributors and future partnerships. Focus areas are a weight-management capsule and an oral drug-delivery device for biologic drugs.
Geographic Exposure
IsraelN/A
United StatesN/A
GermanyN/A
SpainN/A
MexicoN/A
IndiaN/A
Revenue Drivers
Weight-management ingestible devices
Develops and commercializes a non-drug ingestible capsule for satiety.
PERIPHERAL0%
Oral biologics drug-delivery devices
Develops ingestible devices to deliver biologic drugs through the intestinal wall.
PERIPHERAL0%
End Markets
Medical device distributors
Patients with overweight/obesity (prescription home use)
Healthcare professionals (prescribing physicians)
Pharmaceutical and biotech partners (future collaborations for biologics delivery)
Specializations
Polymer hydrogel satiety mechanismSelf-administered ingestible medical devicesPivotal and follow-on clinical trials (RESET study)FDA marketing authorization processCE marking and AMAR medical device registrationISO 13485:2016 quality management system+2 more
Activities
Research and development
Clinical trials and evidence generation
Regulatory approvals and quality management
Manufacturing scale-up
Distributor partnering and commercialization planning
